rs3746808

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033409.4(SLC52A3):​c.321C>T​(p.Ala107Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.303 in 1,609,184 control chromosomes in the GnomAD database, including 76,036 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6025 hom., cov: 31)
Exomes 𝑓: 0.31 ( 70011 hom. )

Consequence

SLC52A3
NM_033409.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.24

Publications

20 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 20-765454-G-A is Benign according to our data. Variant chr20-765454-G-A is described in ClinVar as Benign. ClinVar VariationId is 262233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC52A3NM_033409.4 linkc.321C>T p.Ala107Ala synonymous_variant Exon 2 of 5 ENST00000645534.1 NP_212134.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC52A3ENST00000645534.1 linkc.321C>T p.Ala107Ala synonymous_variant Exon 2 of 5 NM_033409.4 ENSP00000494193.1

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40879
AN:
151932
Hom.:
6014
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.314
Gnomad ASJ
AF:
0.290
Gnomad EAS
AF:
0.225
Gnomad SAS
AF:
0.358
Gnomad FIN
AF:
0.384
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.304
Gnomad OTH
AF:
0.263
GnomAD2 exomes
AF:
0.321
AC:
77035
AN:
240208
AF XY:
0.321
show subpopulations
Gnomad AFR exome
AF:
0.152
Gnomad AMR exome
AF:
0.440
Gnomad ASJ exome
AF:
0.291
Gnomad EAS exome
AF:
0.217
Gnomad FIN exome
AF:
0.378
Gnomad NFE exome
AF:
0.304
Gnomad OTH exome
AF:
0.305
GnomAD4 exome
AF:
0.306
AC:
446195
AN:
1457132
Hom.:
70011
Cov.:
70
AF XY:
0.308
AC XY:
223093
AN XY:
724464
show subpopulations
African (AFR)
AF:
0.155
AC:
5181
AN:
33416
American (AMR)
AF:
0.427
AC:
18616
AN:
43616
Ashkenazi Jewish (ASJ)
AF:
0.298
AC:
7752
AN:
26028
East Asian (EAS)
AF:
0.219
AC:
8648
AN:
39536
South Asian (SAS)
AF:
0.372
AC:
31868
AN:
85772
European-Finnish (FIN)
AF:
0.372
AC:
19749
AN:
53106
Middle Eastern (MID)
AF:
0.277
AC:
1593
AN:
5760
European-Non Finnish (NFE)
AF:
0.302
AC:
335324
AN:
1109680
Other (OTH)
AF:
0.290
AC:
17464
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
22368
44736
67104
89472
111840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11076
22152
33228
44304
55380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40909
AN:
152052
Hom.:
6025
Cov.:
31
AF XY:
0.274
AC XY:
20375
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.161
AC:
6686
AN:
41510
American (AMR)
AF:
0.315
AC:
4811
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.290
AC:
1006
AN:
3470
East Asian (EAS)
AF:
0.225
AC:
1165
AN:
5170
South Asian (SAS)
AF:
0.358
AC:
1719
AN:
4800
European-Finnish (FIN)
AF:
0.384
AC:
4057
AN:
10568
Middle Eastern (MID)
AF:
0.282
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
0.304
AC:
20640
AN:
67950
Other (OTH)
AF:
0.262
AC:
551
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1483
2967
4450
5934
7417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.288
Hom.:
21839
Bravo
AF:
0.260
Asia WGS
AF:
0.317
AC:
1099
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala107Ala in exon 2 of SLC52A3: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 52.10% (4717/9054) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.br oadinstitute.org; dbSNP rs3746808). -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brown-Vialetto-van Laere syndrome 1 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Progressive bulbar palsy of childhood Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.6
DANN
Benign
0.37
PhyloP100
2.2
PromoterAI
-0.010
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746808; hg19: chr20-746098; COSMIC: COSV54077309; API